查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1652684

化妝品勝□製造市場：全球產業分析、市場規模、佔有率、成長、趨勢與未來預測（2025-2032）

Cosmetic Peptide Manufacturing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 224 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發佈了一份關於全球化妝品勝□製造市場的綜合報告。該報告對市場推動因素、趨勢、機會、推動因素和課題等關鍵市場動態進行了全面的評估，並對市場結構提供了詳細的見解。本研究報告提供了獨家數據和統計數據，概述了 2025 年至 2032 年全球化妝品勝□製造市場的預期成長軌跡。

主要的洞察

  • 化妝品勝□製造市場規模（2025 年）：2.599 億美元
  • 預測市場規模（價值基礎，2032 年）：4.069 億美元
  • 全球市場成長率（CAGR，2025-2032）：6.60%

化妝品勝□製造市場：分析範圍

化妝品勝□是一種生物活性成分，在促進皮膚健康、減少老化跡象和促進年輕外表方面發揮重要作用。這些勝□通常被添加到乳霜、乳液和精華液等護膚產品中，以提供抗衰老、緊緻和恢復活力的功效。該市場迎合各種化妝品製造商，包括全球護膚品牌、皮膚病診所和美容院。化妝品勝□製造市場的成長得益於對有效抗衰老解決方案的需求不斷增長、對基於勝□的護膚產品的認識不斷提高以及勝□合成和製造技術的不斷進步。

市場成長動力：

全球化妝品勝□製造市場受到幾個關鍵因素的推動，包括消費者對抗老化產品的需求不斷增加以及對基於勝□的皮膚護理解決方案的偏好日益增加。人們越來越意識到勝□在改善皮膚彈性、減少皺紋和改善整體皮膚外觀方面的功效，這極大地促進了對這些成分的需求。此外，勝□合成技術的進步使得生產更有效率、更具成本效益，進而推動了市場的成長。個人化護膚解決方案的日益普及和全球護膚品產業的擴張進一步推動了對高品質化妝品勝□的需求。

市場限制：

儘管成長前景看好，但化妝品勝□製造市場面臨著與勝□合成的複雜性、高製造成本和監管障礙相關的課題。勝□的製造過程需要先進的技術和對分子結構的精確控制，因此成本較高。此外，人們對某些勝□的安全性和有效性存在擔憂，監管審查可能會延遲新產品進入市場。製造商必須克服這些課題，以保持其□基產品的質量，同時確保遵守嚴格的法規。

市場機會：

由於技術進步、消費者偏好的不斷變化以及對皮膚健康的日益關注，化妝品勝□製造市場提供了巨大的成長機會。開發具有增強的抗衰老和皮膚再生功效的新型勝□為市場參與者擴大其產品組合提供了良好的機會。此外，人們對天然和永續美容產品的日益關注為採用植物源勝□和環保製造流程創造了有利的環境。勝□製造商和化妝品品牌合作開發創新、高性能產品為持續的市場擴張指明了方向。

本報告解答的關鍵問題

  • 推動全球化妝品勝□製造市場成長的關鍵因素有哪些？
  • 哪些類型的勝□推動了基於勝□的護膚產品的採用？
  • 勝□合成技術的進步如何改變製造流程和產品供應？
  • 哪些主要公司為化妝品勝□製造市場做出了貢獻？他們採用什麼策略來維持市場領導地位？
  • 全球化妝品勝□製造市場的新興趨勢和未來前景是什麼？

目錄

第 1 章執行摘要

第2章 市場概覽

  • 市場範圍與定義
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題
    • 主要趨勢
  • 技術生命週期分析
  • 化妝品勝□製造市場：價值鏈
    • 原料供應商名單
    • 製造商列表
    • 經銷商名單
    • 用途列表
    • 獲利能力分析
  • 波特五力分析
  • 地緣政治緊張局勢：市場影響
  • 宏觀經濟因素
    • 全球產業展望
    • 全球 GDP 成長前景
    • 全球母公司市場概覽
  • 預測因子：相關性和影響力
  • 監管與技術格局

第 3 章全球化妝品勝□製造市場展望：過去（2019-2023 年）與預測（2025-2032 年）

  • 主要亮點
    • 市場規模預測（基於數量）
    • 市場規模與年成長率
    • 絕對的獲利機會
  • 市場規模分析與預測（價值基礎（百萬美元））
    • 過往市場規模分析（2019-2023 年）
    • 當前市場規模預測（2025-2032）
  • 全球化妝品勝□製造市場（按產品）展望
    • 簡介/主要發現
    • 按產品劃分的歷史市場規模表現（價值（百萬美元）和數量，2019 年至 2023 年）
    • 按產品劃分的當前市場規模預測（價值（百萬美元）和數量，2025 年至 2032 年）
      • 信號□
      • 神經傳導物質抑制劑
      • 載體勝□
      • 酵素抑制勝□
      • 結構勝□
      • 合成抗菌勝□（Amp）
      • 其他
  • 依產品進行市場吸引力分析
  • 全球化妝品勝□製造市場應用前景
    • 簡介/主要發現
    • 按應用劃分的歷史市場規模表現（價值（百萬美元）和數量，2019 年至 2023 年）
    • 按應用劃分的當前市場規模預測（價值（百萬美元）和數量，2025 年至 2032 年）
      • 抗衰老
      • 眼部護理
      • 防止色素沉著
      • 頭髮生長
  • 按應用程式進行市場吸引力分析
  • 全球化妝品勝□製造市場前景（依最終用戶）
    • 簡介/主要發現
    • 以最終用戶劃分的歷史市場規模表現（價值（百萬美元）和數量，2019 年至 2023 年）
    • 按最終用戶劃分的當前市場規模預測（價值（百萬美元）和數量，2025 年至 2032 年）
      • 化妝品製造商
      • 化妝品合約製造商
      • 生物製藥業（個人護理）
  • 按最終用戶進行市場吸引力分析
第4章 全球化妝品勝□製造市場區域展望
  • 主要亮點
  • 按地區劃分的歷史市場規模分析（價值（百萬美元）和數量，2019 年至 2023 年）
  • 按地區劃分的當前市場規模預測（價值（百萬美元）和數量，2025 年至 2032 年）
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 按地區進行市場吸引力分析

第 5 章北美化妝品勝□製造市場展望：歷史（2019-2023）與預測（2025-2032）

第 6 章歐洲化妝品勝□製造市場展望：歷史（2019-2023 年）與預測（2025-2032 年）

第 7 章 東亞化妝品勝□製造市場展望：過去（2019-2023 年）與預測（2025-2032 年）

第 8 章 南亞和大洋洲化妝品勝□製造市場展望：歷史（2019-2023 年）和預測（2025-2032 年）

第 9 章拉丁美洲化妝品勝□製造市場展望：歷史（2019-2023 年）與預測（2025-2032 年）

第 10 章中東和非洲化妝品勝□製造市場展望：歷史（2019-2023 年）和預測（2025-2032 年）

第 11 章 競爭格局

  • 市佔率分析（2024年）
  • 市場結構
    • 競爭加劇圖：依市場劃分
    • 競爭資訊中心
    • 生產能力（表觀值）
  • 公司簡介（詳情：概述、財務狀況、策略、最新發展）
    • Croda International Plc
    • Ashland
    • DSM[Koninklijke DSM NV]
    • Bachem
    • Genscript Biotech Corp
    • BASF SE
    • Geltor
    • The Lubrizol Corporation
    • Symrise
    • Bio basic Inc.
    • Regeron Inc.

第 12 章附錄

  • 研究方法
  • 調查前提
  • 縮寫和縮寫
簡介目錄
Product Code: PMRREP33714

Persistence Market Research has recently released a comprehensive report on the worldwide market for cosmetic peptide manufacturing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global cosmetic peptide manufacturing market from 2025 to 2032.

Key Insights:

  • Cosmetic Peptide Manufacturing Market Size (2025E): USD 259.9 Million
  • Projected Market Value (2032F): USD 406.9 Million
  • Global Market Growth Rate (CAGR 2025 to 2032):6.60%

Cosmetic Peptide Manufacturing Market - Report Scope:

Cosmetic peptides are bioactive ingredients that play a vital role in enhancing skin health, reducing signs of aging, and promoting a youthful appearance. These peptides are commonly incorporated into skincare products such as creams, lotions, and serums, offering benefits such as anti-aging, firming, and skin rejuvenation. The market caters to various cosmetic manufacturers, including global skincare brands, dermatological clinics, and beauty salons. The growth of the cosmetic peptide manufacturing market is driven by the rising demand for effective anti-aging solutions, increased awareness of peptide-based skincare products, and continuous advancements in peptide synthesis and manufacturing techniques.

Market Growth Drivers:

The global cosmetic peptide manufacturing market is propelled by several key factors, including growing consumer demand for anti-aging products and increased preference for peptide-based skincare solutions. The rising awareness regarding the effectiveness of peptides in improving skin elasticity, reducing wrinkles, and enhancing overall skin appearance contributes significantly to the demand for these ingredients. Additionally, advancements in peptide synthesis technologies, which allow for more efficient and cost-effective production, are supporting market growth. The increasing popularity of personalized skincare solutions and the expansion of the global skincare industry further enhance the demand for high-quality cosmetic peptides.

Market Restraints:

Despite promising growth prospects, the cosmetic peptide manufacturing market faces challenges related to the complexity of peptide synthesis, high production costs, and regulatory hurdles. The process of manufacturing peptides involves sophisticated techniques and precise control over molecular structures, which can be costly. Additionally, there are concerns regarding the safety and efficacy of certain peptides, leading to regulatory scrutiny that can delay market entry for new products. Manufacturers must navigate these challenges to ensure compliance with stringent regulations while maintaining the quality of their peptide-based products.

Market Opportunities:

The cosmetic peptide manufacturing market presents significant growth opportunities driven by technological advancements, evolving consumer preferences, and the growing emphasis on skin health. The development of novel peptides with enhanced anti-aging and skin-rejuvenating properties offers promising opportunities for market players to expand their product portfolios. Furthermore, the increasing focus on natural and sustainable beauty products creates a favorable environment for the introduction of plant-based peptides and eco-friendly manufacturing processes. Collaborations between peptide manufacturers and cosmetic brands to develop innovative, high-performance products present an avenue for continued market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the cosmetic peptide manufacturing market globally?
  • Which types of peptides are driving the adoption of peptide-based skincare products?
  • How are advancements in peptide synthesis technologies reshaping the manufacturing process and product offerings?
  • Who are the key players contributing to the cosmetic peptide manufacturing market, and what strategies are they employing to maintain market leadership?
  • What are the emerging trends and future prospects in the global cosmetic peptide manufacturing market?

Competitive Intelligence and Business Strategy:

Leading players in the global cosmetic peptide manufacturing market, including companies like BASF SE, Evonik Industries, and Givaudan, focus on innovation, product differentiation, and strategic partnerships to maintain a competitive edge. These companies invest in research and development to create advanced peptide formulations that offer superior anti-aging, moisturizing, and skin-smoothing benefits. Collaborations with cosmetic brands and skincare product manufacturers facilitate market penetration and the introduction of cutting-edge peptide-based formulations. Additionally, expanding R&D efforts into sustainable peptide sourcing and eco-friendly manufacturing practices enhances the appeal of these ingredients among environmentally conscious consumers.

Key Companies Profiled:

  • BASF SE
  • Evonik Industries
  • Givaudan
  • DSM Nutritional Products
  • Sederma Inc.
  • Clariant AG
  • Croda International Plc
  • Kobo Products Inc.
  • Peptitec
  • Tri-K Industries, Inc.

Cosmetic Peptide Manufacturing Market Research Segmentation

By Product:

  • Signal Peptides
  • Neurotransmitter Inhibitors
  • Carrier Peptides
  • Enzyme Inhibitor Peptides
  • Structural Peptides
  • Synthetic Antimicrobial Peptides (Amps)

By Application:

  • Anti-Aging
  • Eye Care
  • Anti Pigmentation
  • Hair Growth

By End User:

  • Cosmetic Manufacturers
  • Cosmetic Contract Manufacturers
  • Biopharmaceutical Industries (Personal care)

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Cosmetic Peptide Manufacturing Market Snapshot, 2025 - 2032
  • 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Lifecycle Analysis
  • 2.4. Cosmetic Peptide Manufacturing Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global Cosmetic Peptide Manufacturing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2019 - 2023
    • 3.2.2. Current Market Size Forecast, 2025 - 2032
  • 3.3. Global Cosmetic Peptide Manufacturing Market Outlook: Product
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2019 - 2023
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2025 - 2032
      • 3.3.3.1. Signal Peptides
      • 3.3.3.2. Neurotransmitter Inhibitors
      • 3.3.3.3. Carrier Peptides
      • 3.3.3.4. Enzyme Inhibitor Peptides
      • 3.3.3.5. Structural Peptides
      • 3.3.3.6. Synthetic Antimicrobial Peptides (Amps)
      • 3.3.3.7. Others
  • 3.4. Market Attractiveness Analysis: Product
  • 3.5. Global Cosmetic Peptide Manufacturing Market Outlook: End User
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2019 - 2023
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
      • 3.5.3.1. Anti-Aging
      • 3.5.3.2. Eye Care
      • 3.5.3.3. Anti-Pigmentation
      • 3.5.3.4. Hair Growth
  • 3.6. Market Attractiveness Analysis: End User
  • 3.7. Global Cosmetic Peptide Manufacturing Market Outlook: End User
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2019 - 2023
    • 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
      • 3.7.3.1. Cosmetic Manufacturers
      • 3.7.3.2. Cosmetic Contract Manufacturers
      • 3.7.3.3. Biopharmaceutical Industries (Personal care)
  • 3.8. Market Attractiveness Analysis: End User

4. Global Cosmetic Peptide Manufacturing Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019 - 2023
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2025 - 2032
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia & Pacific
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Cosmetic Peptide Manufacturing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 5.3.1. By Country
    • 5.3.2. By Product
    • 5.3.3. By Application
    • 5.3.4. By End User
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 5.5.1. Signal Peptides
    • 5.5.2. Neurotransmitter Inhibitors
    • 5.5.3. Carrier Peptides
    • 5.5.4. Enzyme Inhibitor Peptides
    • 5.5.5. Structural Peptides
    • 5.5.6. Synthetic Antimicrobial Peptides (Amps)
    • 5.5.7. Others
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2025 - 2032
    • 5.6.1. Anti-Aging
    • 5.6.2. Eye Care
    • 5.6.3. Anti Pigmentation
    • 5.6.4. Hair Growth
  • 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 5.7.1. Cosmetic Manufacturers
    • 5.7.2. Cosmetic Contract Manufacturers
    • 5.7.3. Biopharmaceutical Industries (Personal care)
  • 5.8. Market Attractiveness Analysis

6. Europe Cosmetic Peptide Manufacturing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 6.3.1. By Country
    • 6.3.2. By Product
    • 6.3.3. By Application
    • 6.3.4. By End User
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkey
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 6.5.1. Signal Peptides
    • 6.5.2. Neurotransmitter Inhibitors
    • 6.5.3. Carrier Peptides
    • 6.5.4. Enzyme Inhibitor Peptides
    • 6.5.5. Structural Peptides
    • 6.5.6. Synthetic Antimicrobial Peptides (Amps)
    • 6.5.7. Others
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2025 - 2032
    • 6.6.1. Anti-Aging
    • 6.6.2. Eye Care
    • 6.6.3. Anti Pigmentation
    • 6.6.4. Hair Growth
  • 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 6.7.1. Cosmetic Manufacturers
    • 6.7.2. Cosmetic Contract Manufacturers
    • 6.7.3. Biopharmaceutical Industries (Personal care)
  • 6.8. Market Attractiveness Analysis

7. East Asia Cosmetic Peptide Manufacturing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By Application
    • 7.3.4. By End User
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 7.5.1. Signal Peptides
    • 7.5.2. Neurotransmitter Inhibitors
    • 7.5.3. Carrier Peptides
    • 7.5.4. Enzyme Inhibitor Peptides
    • 7.5.5. Structural Peptides
    • 7.5.6. Synthetic Antimicrobial Peptides (Amps)
    • 7.5.7. Others
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2025 - 2032
    • 7.6.1. Anti-Aging
    • 7.6.2. Eye Care
    • 7.6.3. Anti Pigmentation
    • 7.6.4. Hair Growth
  • 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 7.7.1. Cosmetic Manufacturers
    • 7.7.2. Cosmetic Contract Manufacturers
    • 7.7.3. Biopharmaceutical Industries (Personal care)
  • 7.8. Market Attractiveness Analysis

8. South Asia & Oceania Cosmetic Peptide Manufacturing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By Application
    • 8.3.4. By End User
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 8.5.1. Signal Peptides
    • 8.5.2. Neurotransmitter Inhibitors
    • 8.5.3. Carrier Peptides
    • 8.5.4. Enzyme Inhibitor Peptides
    • 8.5.5. Structural Peptides
    • 8.5.6. Synthetic Antimicrobial Peptides (Amps)
    • 8.5.7. Others
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2025 - 2032
    • 8.6.1. Anti-Aging
    • 8.6.2. Eye Care
    • 8.6.3. Anti Pigmentation
    • 8.6.4. Hair Growth
  • 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 8.7.1. Cosmetic Manufacturers
    • 8.7.2. Cosmetic Contract Manufacturers
    • 8.7.3. Biopharmaceutical Industries (Personal care)
  • 8.8. Market Attractiveness Analysis

9. Latin America Cosmetic Peptide Manufacturing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By Application
    • 9.3.4. By End User
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 9.5.1. Signal Peptides
    • 9.5.2. Neurotransmitter Inhibitors
    • 9.5.3. Carrier Peptides
    • 9.5.4. Enzyme Inhibitor Peptides
    • 9.5.5. Structural Peptides
    • 9.5.6. Synthetic Antimicrobial Peptides (Amps)
    • 9.5.7. Others
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2025 - 2032
    • 9.6.1. Anti-Aging
    • 9.6.2. Eye Care
    • 9.6.3. Anti Pigmentation
    • 9.6.4. Hair Growth
  • 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 9.7.1. Cosmetic Manufacturers
    • 9.7.2. Cosmetic Contract Manufacturers
    • 9.7.3. Biopharmaceutical Industries (Personal care)
  • 9.8. Market Attractiveness Analysis

10. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Application
    • 10.3.4. By End User
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 10.5.1. Signal Peptides
    • 10.5.2. Neurotransmitter Inhibitors
    • 10.5.3. Carrier Peptides
    • 10.5.4. Enzyme Inhibitor Peptides
    • 10.5.5. Structural Peptides
    • 10.5.6. Synthetic Antimicrobial Peptides (Amps)
    • 10.5.7. Others
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application,2025 - 2032
    • 10.6.1. Anti-Aging
    • 10.6.2. Eye Care
    • 10.6.3. Anti Pigmentation
    • 10.6.4. Hair Growth
  • 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 10.7.1. Cosmetic Manufacturers
    • 10.7.2. Cosmetic Contract Manufacturers
    • 10.7.3. Biopharmaceutical Industries (Personal care)
  • 10.8. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2024
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Neurotransmitter Inhibitors
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Croda International Plc
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Ashland
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. DSM [Koninklijke DSM NV]
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Bachem
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Genscript Biotech Corp
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. BASF SE
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Geltor
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. The Lubrizol Corporation
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Symrise
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Bio basic Inc.
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. Regeron Inc.
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Product
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations